title: [Expression of survivin and its significance in esophageal cancer].
abstract: OBJECTIVE
  To detect the expression of survivin in esophageal cancer and elucidate its function in esophageal cancer.
  
  
  METHODS
  Expression of surviv in was detected in paired normal and tumor tissues from patients with esophageal cancer by semi-quantitative RT-PCR. A dominant-negative survivin (surT34A) was transfected into esophageal cancer EC9706 cells (EC9706surT34A). Colony formation and apoptosis of the parental and surT34A-transfected EC9706 cells were examined in soft agar and by flow cytometry, respectively.
  
  
  RESULTS
  Survivin mRNA expression of tumor tissues was higher than normal tissues in 18/27 (66.7%) samples. The expression level of survivin mRNA in tumor tissues (2.08 +/- 1.32) was significantly higher than that in normal tissues (1.22 +/- 1.09). EC9706 surT34A cells formed fewer colonies on agar than the non-transfected ones. After serum withdrawal, EC9706surT34A had higher apoptotic ratio than control, but survivin could reduce the apoptotic ratio.
  
  
  CONCLUSIONS
  Overexpression of survivin is a common eventin esophageal cancer. The dominant-negative survivin can partially inhibit the malignant phenotype of esophageal cancer.
authors.affiliation: Laboratory of Cell and Molecular Biology, Cancer Institute (Hospital), Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100021, China.
authors.forename: Hong-Xia
authors.initials: HX
authors.lastname: Zhu
authors.forename: Yi-Hua
authors.initials: YH
authors.lastname: Wang
authors.forename: Cui-Qi
authors.initials: CQ
authors.lastname: Zhou
authors.forename: Guo
authors.initials: G
authors.lastname: Zhang
authors.forename: Jin-Feng
authors.initials: JF
authors.lastname: Bai
authors.forename: Lan-Ping
authors.initials: LP
authors.lastname: Quan
authors.forename: Zhi-Hua
authors.initials: ZH
authors.lastname: Liu
authors.forename: Ning-Zhi
authors.initials: NZ
authors.lastname: Xu
mesh_terms: D000368:Aged; D017209:Apoptosis; D002294:Carcinoma, Squamous Cell / Q000378:metabolism* / Q000473:pathology; D045744:Cell Line, Tumor; D004938:Esophageal Neoplasms / Q000378:metabolism* / Q000473:pathology; D005260:Female; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D051034:Inhibitor of Apoptosis Proteins; D008297:Male; D008869:Microtubule-Associated Proteins / Q000096:biosynthesis* / Q000235:genetics / Q000502:physiology; D008875:Middle Aged; D009154:Mutation; D009363:Neoplasm Proteins / Q000096:biosynthesis* / Q000235:genetics / Q000502:physiology; D012333:RNA, Messenger / Q000096:biosynthesis / Q000235:genetics; D000077022:Survivin; D014162:Transfection
chemical_list: C107489:BIRC5 protein, human; D051034:Inhibitor of Apoptosis Proteins; D008869:Microtubule-Associated Proteins; D009363:Neoplasm Proteins; D012333:RNA, Messenger; D000077022:Survivin